HippoFi Enters Strategic Alliance with Zimmer Biomet

HippoFi entered into a partnership with Zimmer Biomet to introduce a novel synthetic biomaterial for bone growth, set for a 2024 launch under HippoFi’s biologic subsidiary, PUR Biologics.

HippoFi/PUR gained FDA 510(K) clearance for ActiveOrb technology, and secured from Zimmer Biomet an exclusive global license to the underlying technology for...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us